ArticlePloS one2013

Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair.

Yinchuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.